Excisanin A is primarily used in pharmaceutical research for its potential anti-inflammatory and immunomodulatory properties. It has shown activity in inhibiting certain signaling pathways involved in inflammatory responses, making it a candidate for development in treatments targeting autoimmune diseases and chronic inflammation. Studies also suggest its role in promoting wound healing and tissue regeneration due to its influence on cell proliferation and collagen synthesis. Additionally, Excisanin A is investigated for its antiviral effects, particularly in interfering with viral replication mechanisms. Its natural origin and bioactivity make it valuable in exploring new herbal-based therapeutics and drug leads.